CanadianHealthPolicy retweeted
Today, SecondStreet.org, in collaboration with five other organizations, released an open letter to the Prime Minister giving him credit for letting provinces like Alberta experiment with health care reform. Read the letter below or on our website, here: bit.ly/4uE2eGu
@iedm_montreal @CDNConstFound @ConsumerChoiceC @CHPI1 @MLInstitute
CanadianHealthPolicy retweeted
Opinion: National pharmacare will reduce drug access for almost 26 million Canadians financialpost.com/opinion/ph…
CanadianHealthPolicy retweeted
Cancer is the leading cause of death in Canada, but public drug plans cover only 11% of new cancer drugs, Canadians wait 1,835 days for coverage, and sales of new cancer drugs are only 1.3% of national health expenditure: new study. #cdnpoli #cdnecon canadianhealthpolicy.com
CanadianHealthPolicy retweeted
New study: Economic burden of cardiomyopathy $5 billion/yr. Patented drugs account for less than 1%. As first line therapy pharmaceutical innovation offers opportunity to avoid downstream hospital cost, productivity loss, mortality. #cdnhealth #cdnpoli canadianhealthpolicy.com
CanadianHealthPolicy retweeted
Study finds federal changes to patented medicines regulations linked to fewer new drugs in Canada versus the United States and Europe.
canadianhealthpolicy.com/pro… #Pharmaceutical #health #Canada
CanadianHealthPolicy retweeted
New paper by CHPI's Mayvis Rebeira PhD reviews limitations of using quality-adjusted life-years (QALYs) in health technology assessments. Insurance coverage for new therapies should not be solely based on subjective uncertain HTA metrics. canadianhealthpolicy.com/pro…
CanadianHealthPolicy retweeted
Lengthy wait times have some B.C. cancer patients dying before their first consultations. “Many patients are choosing MAID because of both their physical suffering with ..cancer and the mental suffering of not knowing when they’ll hear their options”… theglobeandmail.com/canada/b…
CanadianHealthPolicy retweeted
Another great article from CHPI's Nigel Rawson and John Adams in the Financial Post -- Suffer from a rare disorder in Canada? Good luck: Canadians with rare disorders are often on their own in trying to get health care. financialpost.com/opinion/ra… #healthcare #canada
CanadianHealthPolicy retweeted
Read CHPI CEO Brett Skinner in the Hill Times on why drug price regulation is bad policy making: hilltimes.com/2022/07/04/is-… #cdnpoli
CanadianHealthPolicy retweeted
Read CHPI CEO Brett Skinner comment in the Financial Post about why drug price regulation is unnecessary and harmful: financialpost.com/opinion/br… #cdnpoli
CanadianHealthPolicy retweeted
From 1st global new drug application to formulary listing in a public drug plan, Canadians waited up to 3.8 years longer than Americans, 3.6 yrs longer than Germans. New study: Waiting for new medicines in Canada, Europe and the United States 2016-2021 canadianhealthpolicy.com
CanadianHealthPolicy retweeted
Public drug plans covered only 24% of new drugs, compared to 64% in private drug plans. The insurance coverage delay in public drug plans was 724 days compared to 227 days in private drug plans. New study: Access to new medicines in Canada 2016–2021. canadianhealthpolicy.com
CanadianHealthPolicy retweeted
New article published in Canadian Health Policy Journal: canadianhealthpolicy.com/
Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19 by Sarah Lussier-Hoskyn MA Economics, Brett Skinner PhD, Canadian Health Policy Institute
CanadianHealthPolicy retweeted
New article published in Canadian Health Policy Journal: canadianhealthpolicy.com/
Why would Canada have the longest wait times for an Alzheimer’s treatment among the G7 countries? By Soeren Mattke MD DSc, Mo Wang MS, University of Southern California
CanadianHealthPolicy retweeted
Canadian Health Policy Institute celebrates 10th anniversary! New style for CHP Journal. canadianhealthpolicy.com
CanadianHealthPolicy retweeted
NEW BOOK - Rogue Regulator: PMPRB’s false narrative is driving dangerous drug price controls. By Brett Skinner PhD. JAN 2022 regulatory changes will reduce availability of new drugs and discourage clinical research in Canada. canadianhealthpolicy.com/pro… #cdnpoli #cdnhealth
CanadianHealthPolicy retweeted
Latest article by Dr Nigel Rawson a must read for those interested in the impact of new price regulations on clinical research in Canada. "PMPRB’s Selective Use of Undefined Data Is Intended to Further its Misleading Narrative." canadianhealthpolicy.com/blo… #pmprb #cdnpoli #cdnhealth
CanadianHealthPolicy retweeted
Read study by Nigel Rawson, PhD: Availability and Accessibility of Essential Drugs for Rare Disorders in Canada. Only 85% of drugs available in the US were available in CAN and gov't drug plans cover few of these medicines doi.org/10.54194/HFEB4050
#cdnpoli #cdnhealth #cadth #pcpa
CanadianHealthPolicy retweeted
NEW paper: Canada’s COVID-19 Vaccine Procurement Strategy: Comparisons with the United Kingdom and Israel by Mayvis Rebeira, PhD canadianhealthpolicy.com/pro… #cdnpoli #cdnhealth
CanadianHealthPolicy retweeted
Politically-instituted barriers against innovative medicines have a human toll. Read this moving blog article by Nigel Rawson and Beth Vanstone: canadianhealthpolicy.com/blo…. Beth’s daughter, Madi, has cystic fibrosis. Her urgent need for a new medicine is being ignored by government.

















